Please login to the form below

Not currently logged in
Email:
Password:

umeclidinium

This page shows the latest umeclidinium news and features for those working in and with pharma, biotech and healthcare.

GSK seeks EU approval for Trelegy in adult asthma patients

GSK seeks EU approval for Trelegy in adult asthma patients

Triple respiratory drug Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is already approved in the EU and US for use in chronic obstructive pulmonary disease (COPD) patients, although GSK is now keen

Latest news

More from news
Approximately 9 fully matching, plus 54 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...